PrEP/PEP
PrEP (Pre-Exposure Prophylaxis)
Is a comprehensive HIV prevention strategy that involves the daily use of antiretroviral medications to reduce the risk of HIV infection in HIV-negative individuals. In July 2012, the US Food and Drug Administration approved the use of Truvada (TDF/FTC) for use as PrEP in HIV prevention in sexually active HIV–negative individuals. PrEP should be used in conjunction with other prevention methods to reduce the risk of infection.
PrEP Resources:
(All links open in a new window)
CDC PrEP
http://www.cdc.gov/hiv/prep/
CDC PrEP Fact Sheet
http://www.cdc.gov/hiv/prep/pdf/PREPfactsheet.pdf
Truvada for PrEP Fact Sheet
http://www.fda.gov/downloads/NewsEvents/Newsroom/FactSheets/UCM312279.pdf
PrEP Webinar (HIV Prevention Program, HIV/AIDS and Hepatitis Section, FL DOH)
http://www.doh.state.fl.us/Disease_ctrl/aids/prevention/PrEP_Science_Webinar.pdf
AETC- PrEP
http://www.aids-ed.org/aidsetc?page=home-search&post=1&SearchEntry=PrEP
AIDSinfo- PrEP
http://aidsinfo.nih.gov/Guidelines
AIDS.gov
http://search.aids.gov/search?q=PrEP&entqr=0&output=xml_no_dtd&sort=date%3AD%3AL%3Ad1&ud=1&client=aids_gov&oe=UTF-8&ie=UTF-8&proxystylesheet=aids_gov&site=aids_gov
PEP (Post Exposure Prophylaxis)
Post Exposure Prophylaxis (PEP) involves taking antiretroviral medications as soon as possible after a potential exposure to HIV to reduce the likelihood of HIV infection. There are two types of PEP: 1) occupational PEP, or an exposure that happens in the workplace (such as a needle stick in a healthcare setting), and 2) non-occupational PEP (nPEP), or when someone is potentially exposed to HIV through sexual intercourse or injection drug use.
To be effective, PEP must begin with 72 hours of exposure and consists of 2-3 antiretroviral medications that must be taken for 28 days. A physician must determine what treatment is appropriate based on the nature of the exposure. Starting PEP after a potential exposure does not guarantee that someone exposed to HIV will not become infected.
PEP Resources:
(All links open in a new window)
July 2013 Updated Guidelines for HIV Prophylaxis Following Non-Occupational Exposure (nPEP)
Prophylaxis-Following-Non-Occupational-Exposure.pdf
AETC- PEP Information
http://www.aids-ed.org/aidsetc?page=home-search&post=1&SearchEntry=PEP
CDC- Antiretroviral Treatment for Prevention of HIV Transmission
http://www.cdc.gov/hiv/prevention/programs/pwp/art.html
AIDS.gov- PEP Resources
http://aids.gov/hiv-aids-basics/prevention/reduce-your-risk/post-exposure-prophylaxis/
Non-Occupational PEP Guidelines
http://aidsinfo.nih.gov/contentfiles/NonOccupationalExposureGL.pdf
Occupational PEP Guidelines
http://aidsinfo.nih.gov/contentfiles/HealthCareOccupExpoGL.pdf
OSHA Fact Sheet- Bloodborne Pathogen Exposure Incidents
http://www.osha.gov/OshDoc/data_BloodborneFacts/bbfact04.pdf
For information regarding medication assistance
http://www.truvada.com/truvada-patient-assistance
